Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Lung Neoplasms 84 Prostatic Neoplasms 73 Leukemia, Myeloid, Acute 73 Carcinoma, Non-Small-Cell Lung 61 Neoplasm Metastasis 60 Breast Neoplasms 56 Multiple Myeloma 47 Colorectal Neoplasms 47 Pancreatic Neoplasms 43 Melanoma 36 Carcinoma, Renal Cell 36 Myelodysplastic Syndromes 35 Ovarian Neoplasms 33 Leukemia, Lymphocytic, Chronic, B-Cell 30 Triple Negative Breast Neoplasms 28 Glioblastoma 28 Precursor Cell Lymphoblastic Leukemia-Lymphoma 27 Lymphoma, Large B-Cell, Diffuse 26 Urinary Bladder Neoplasms 25 Lymphoma 23 Squamous Cell Carcinoma of Head and Neck 22 Burkitt Lymphoma 22 Fallopian Tube Neoplasms 21 Glioma 20 Carcinoma, Hepatocellular 20 Brain Neoplasms 18 Mouth Neoplasms 17 Lymphoma, Non-Hodgkin 17 Leukemia, Biphenotypic, Acute 17 Endometrial Neoplasms 17

Interventions

Specimen Handling 1 Physical Examination 1 Metformin 1 Mastectomy, Subcutaneous 1 Mastectomy 1 Diffusion Magnetic Resonance Imaging 1 Colonoscopy 1 Arsenic Trioxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Li-Fraumeni Syndrome × Specimen Handling × Clear all

NCT04541654 2026-03-27

LiFT_UP

Dana-Farber Cancer Institute

Neoplastic Syndromes, Hereditary, Li-Fraumeni Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡